Search Results - "Golakoti, T"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1
  2. 2

    Preclinical anticancer activity of cryptophycin-8 by Corbett, T H, Valeriote, F A, Demchik, L, Polin, L, Panchapor, C, Pugh, S, White, K, Knight, J, Jones, J, Jones, L, LoRusso, P, Foster, B, Wiegand, R A, Lisow, L, Golakoti, T, Heltzel, C E, Ogino, J, Patterson, G M, Moore, R E

    “…Cryptophycin-8 was prepared by the conversion of the epoxide group on cryptophycin-1 to a chlorohydrin. In the studies reported here, cryptophycin-8 was…”
    Get more information
    Journal Article
  3. 3

    Neuroprotective and antiinflammatory properties of a novel demethylated curcuminoid by Khanna, Savita, Park, Han-A, Sen, Chandan K, Golakoti, Trimurtulu, Sengupta, Krishanu, Venkateswarlu, Somepalli, Roy, Sashwati

    Published in Antioxidants & redox signaling (01-03-2009)
    “…A demethylated derivative of curcumin (DC; 67.8% bisdemethylcurcumin, 20.7% demethylmonodemethoxycurcumin, 5.86% bisdemethoxycurcumin, 2.58% demethylcurcumin)…”
    Get more information
    Journal Article
  4. 4

    Biosynthesis of 4-Methylproline in Cyanobacteria:  Cloning of nosE and nosF Genes and Biochemical Characterization of the Encoded Dehydrogenase and Reductase Activities by LUESCH, Hendrik, HOFFMANN, Dietmar, HEVEL, Joan M., BECKER, Julia E., GOLAKOTI, Trimurtulu, MOORE, Richard E.

    Published in Journal of organic chemistry (10-01-2003)
    “…The biosynthesis of the unusual amino acid 4-methylproline in the Nostoc genus of cyanobacteria was investigated on the genetic and enzymatic level. Two genes…”
    Get full text
    Journal Article
  5. 5

    Isolation and Structure Determination of Cryptophycins 38, 326, and 327 from the Terrestrial Cyanobacterium Nostoc sp. GSV 224 by Chaganty, Sreedhara, Golakoti, Trimurtulu, Heltzel, Carl, Moore, Richard E, Yoshida, Wesley Y

    “…Cryptophycin-38 (2), -326 (3), and -327 (4) are three new trace constituents of the terrestrial cyanobacterium Nostoc sp. GSV 224. Cryptophycin-38 is a…”
    Get full text
    Journal Article
  6. 6

    A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin registered for treatment of osteoarthritis of the knee by Sengupta, K, Alluri, K V, Satish, A R, Mishra, S, Golakoti, T, Sarma, KVS, Dey, D, Raychaudhuri, S P

    Published in Arthritis research & therapy (01-01-2008)
    “…Introduction 5-Loxin registered is a novel Boswellia serrata extract enriched with 30% 3-O-acetyl-11-keto-beta-boswellic acid (AKBA), which exhibits potential…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Isolation and Structure Determination of Nostocyclopeptides A1 and A2 from the Terrestrial Cyanobacterium Nostoc sp. ATCC53789 by Golakoti, Trimurtulu, Yoshida, Wesley Y, Chaganty, Sreedhara, Moore, Richard E

    “…The isolation and total structure determination of nostocyclopeptides A1 (1) and A2 (2) are described. These cyclic heptapeptides, which possess a unique imino…”
    Get full text
    Journal Article
  10. 10

    Isolation and Structures of Nostopeptolides A1, A2 and A3 from the Cyanobacterium Nostoc sp. GSV224 by Golakoti, Trimurtulu, Yoshida, Wesley Y., Chaganty, Sreedhara, Moore, Richard E.

    Published in Tetrahedron (10-11-2000)
    “…The isolation and total structure determinations of nostopeptolides A1 ( 1), A2 ( 2) and A3 ( 3) are described. These cyclic depsipeptides, which are devoid of…”
    Get full text
    Journal Article
  11. 11

    Three New Cryptophycins from Nostoc sp. GSV 224 by Subbaraju, Gottumukkala V, Golakoti, Trimurtulu, Patterson, Gregory M. L, Moore, Richard E

    “…Cryptophycin 46 (2), -175 (3), and -176 (4) have been identified as three new trace constituents of Nostoc sp. GSV 224. Cryptophycin-46 is an epimer of…”
    Get full text
    Journal Article
  12. 12

    Treatment of human prostate tumors PC-3 and TSU-PR1 with standard and investigational agents in SCID mice by POLIN, L, VALERIOTE, F, GOLAKOTI, T, PATTERSON, G, MOORE, R, CORBETT, T. H, WHITE, K, PANCHAPOR, C, PUGH, S, KNIGHT, J, LORUSSO, P, HUSSAIN, M, LIVERSIDGE, E, PELTIER, N

    Published in Investigational new drugs (01-01-1997)
    “…Both the PC-3 and the TSU-PR1 prostate tumor models were found to be satisfactory for chemotherapeutic investigations in ICR-SCID mice. The 30 to 60 mg…”
    Get full text
    Journal Article
  13. 13

    Discovery of cryptophycin-1 and BCN-183577 : Examples of strategies and problems in the detection of antitumor activity in mice by CORBETT, T. H, VALERIOTE, F. A, WENTLAND, M, GOLAKOTI, T, HETZEL, C, OGINO, J, PATTERSON, G, MOORE, R, DEMCHIK, L, LOWICHIK, N, POLIN, L, PANCHAPOR, C, PUGH, S, WHITE, K, KUSHNER, J, RAKE, J

    Published in Investigational new drugs (01-01-1997)
    “…Historically, many new anticancer agents were first detected in a prescreen; usually consisting of a molecular/biochemical target or a cellular cytotoxicity…”
    Get full text
    Journal Article